Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Market Cap	7.54B
Revenue (ttm)	8.39B
Net Income (ttm)	810.95M
Shares Out	148.76M
EPS (ttm)	5.45
PE Ratio	9.30
Forward PE	6.96
Dividend	1.50 (2.96%)
Ex-Dividend Date	Apr 22, 2025

Volume	141,938
Average Volume	89,781
Open	50.70
Previous Close	50.70
Day's Range	50.03 - 51.00
52-Week Range	35.06 - 54.70
Beta	0.35
RSI	48.10
Earnings Date	May 25, 2025

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: PHAR

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.